AGC Biologics 與 Child’s Cure Genetic Research 攜手研發針對嚴重癲癇疾病的 mRNA 療法

Choose a language:

Globe NewsWire News Distribution Service

Details: Written by Globe NewsWire Press Releases; Category: Globe NewsWire News Distribution Service; Published: 11 November 2026; Created: 11 November 2026; Last Updated: 11 November 2026

展示 mRNA 技術的全新演進，應對罕見病症

展示 mRNA 技術的全新演進，應對罕見病症

Posted: 2026-11-11 01:13:00

Get Full News Story On GlobeNewsWire Press Release Service

More News From This Category
AGC 바이오로직스, 차일즈 큐어 유전연구재단과 협력해 중증 뇌전증 질환 치료 위한 mRNA 기반 치료제 개발 추진
Wed, 11 Nov 2026 02:08:13 +0000

희귀질환 치료를 위한 mRNA 기술의 새로운 발전 가능성 제시

AGCバイオロジクス、チャイルズ・キュア・ジネティック・リサーチと提携し、重度のてんかん性疾患に対するmRNAベースの治療薬の開発に取り組む
Wed, 11 Nov 2026 02:08:13 +0000

希少疾患への対応に向けたmRNA技術の新たな進化を示す

AGC Biologics bekerjasama dengan Child’s Cure Genetic Research untuk membangunkan terapi berasaskan mRNA bagi merawat gangguan epilepsi yang teruk
Wed, 11 Nov 2026 02:08:13 +0000

Menunjukkan perkembangan baharu dalam teknologi mRNA bagi menangani penyakit jarang

AGC Biologics 与 Child’s Cure Genetic Research 合作开发针对严重癫痫性疾病的 mRNA 疗法
Wed, 11 Nov 2026 02:08:13 +0000

展示 mRNA 在应对罕见病方面的新进展

Related Bing News Results
Globe Newswire, World News and Updates | Toronto Sun
Tue, 10 Nov 2026 07:16:00 GMT
SINGAPORE, Nov. 06, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin ...

Globe Newswire, World News and Updates | Ottawa Sun
Tue, 10 Nov 2026 05:52:00 GMT
LIDKÖPING, Sweden, Nov. 10, 2026 (GLOBE NEWSWIRE) — ASKO Professional made its first-ever appearance at Expodetergo International 2026 in Milan, marking an important step in bringing its Scandinavian ...

🔎 Search This Topic on Popular Platforms